Hitting the target in medulloblastoma therapy

Jane Bradbury. Drug Discov Today. 2004.

. 2004 Dec 1;9(23):994-5.

doi: 10.1016/S1359-6446(04)03289-1.

No abstract available

Similar articles

Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics.
Romer J, Curran T. Romer J, et al. Cancer Res. 2005 Jun 15;65(12):4975-8. doi: 10.1158/0008-5472.CAN-05-0481. Cancer Res. 2005. PMID: 15958535 Review.
New therapy for medulloblastoma tested in mice.
Wildasin K. Wildasin K. Lancet Neurol. 2004 Nov;3(11):640. doi: 10.1016/s1474-4422(04)00897-x. Lancet Neurol. 2004. PMID: 15515241 No abstract available.
Medulloblastoma growth inhibition by hedgehog pathway blockade.
Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM, Beachy PA. Berman DM, et al. Science. 2002 Aug 30;297(5586):1559-61. doi: 10.1126/science.1073733. Science. 2002. PMID: 12202832
Medulloblastoma: signalling a change in treatment.
Gilbertson RJ. Gilbertson RJ. Lancet Oncol. 2004 Apr;5(4):209-18. doi: 10.1016/S1470-2045(04)01424-X. Lancet Oncol. 2004. PMID: 15050952 Review.
The hedgehog pathway and neurological disorders.
Dellovade T, Romer JT, Curran T, Rubin LL. Dellovade T, et al. Annu Rev Neurosci. 2006;29:539-63. doi: 10.1146/annurev.neuro.29.051605.112858. Annu Rev Neurosci. 2006. PMID: 16776596 Review.